CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for RepliCel Life Sciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

RepliCel Life Sciences Inc
570 Granville St Suite 900
Phone: (604) 248-8693p:604 248-8693 VANCOUVER, BC  V6C 3P1  Canada Fax: (604) 248-8730f:604 248-8730
Business Summary
0913693 B.C. Ltd., formerly RepliCel Life Sciences Inc., is a Canada-based company. The Company is not engaged in any business activities. It was previously engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024YesYes---

Industries
SIC Code Description
1040 Gold and silver ores
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board David M.Hall 1/1/2017 12/22/2010
Chief Financial Officer DavidKwok 8/16/2023 8/16/2023
Chief Operating Officer, Corporate Secretary BenAustring 4/21/2023 12/30/2022
Chief Scientific Officer KevinMcelwee 53 1/1/2022 8/22/2011
Independent Director Peter W.Lewis 5/27/2011 5/27/2011

Business Names
Business Name
PAN AMERICAN GOLD CORP
Pan American Gold Corp.
Pan American Gold Corporation
RepliCel Life Sciences
TrichoScience Innovations Inc.

General Information
Number of Employees: 1 (As of 12/31/2021)
Outstanding Shares: 73,577,807 (As of 12/9/2024)
Shareholders: 1,343
Stock Exchange: CVE
Fax Number: (604) 248-8730


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 8, 2025